Highly Bioactive Triterpenoids, Oleanolic and Ursolic Acids: Focus on Their Neuroprotective Potentials

Petrovic, S., Arsic, A., Ristic-Medic, D., Cvetkovic, Z., & Vucic, V. (2020). Lipid peroxidation and antioxidant supplementation in neurodegenerative diseases: a review of human studies. Antioxidants, 9(11), 1128.

Chen, C., Ai, Q., Shi, A., Wang, N., Wang, L., & Wei, Y. (2023). Oleanolic acid and ursolic acid: Therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders. Nutritional Neuroscience, 26(5), 414-428.

Cargnin, S. T., & Gnoatto, S. B. (2017). Ursolic acid from apple pomace and traditional plants: A valuable triterpenoid with functional properties. Food Chemistry, 220, 477-489.

Pironi, A. M., de Araújo, P. R., Fernandes, M. A., Salgado, H. R. N., & Chorilli, M. (2018). Characteristics, biological properties and analytical methods of ursolic acid: A review. Critical Reviews in Analytical Chemistry, 48(1), 86-93.

López-Hortas, L., Pérez-Larrán, P., González-Muñoz, M. J., Falqué, E., & Domínguez, H. (2018). Recent developments on the extraction and application of ursolic acid. A review. Food Research International, 103, 130-149.

Jesus, J. A., Lago, J. H. G., Laurenti, M. D., Yamamoto, E. S., & Passero, L. F. D. (2015). Antimicrobial activity of oleanolic and ursolic acids: an update. Evidence-Based Complementary and Alternative Medicine, 2015.

Gudoityte, E., Arandarcikaite, O., Mazeikiene, I., Bendokas, V., & Liobikas, J. (2021). Ursolic and oleanolic acids: Plant metabolites with neuroprotective potential. International Journal of Molecular Sciences, 22(9), 4599.

Chen, Q., Luo, S., Zhang, Y., & Chen, Z. (2011). Development of a liquid chromatography–mass spectrometry method for the determination of ursolic acid in rat plasma and tissue: application to the pharmacokinetic and tissue distribution study. Analytical and bioanalytical chemistry, 399, 2877-2884.

Ramos-Hryb, A. B., Pazini, F. L., Kaster, M. P., & Rodrigues, A. L. S. (2017). Therapeutic potential of ursolic acid to manage neurodegenerative and psychiatric diseases. Cns Drugs, 31(12), 1029-1041.

Sporn, M. B., Liby, K. T., Yore, M. M., Fu, L., Lopchuk, J. M., & Gribble, G. W. (2011). New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. Journal of natural products, 74(3), 537-545.

Ludeña-Huaman, M. A., & Ramos-lnquiltupa, D. A. (2019). Determination of the content of ursolic and oleanolic acid in the cuticular wax of fruits of different species of Rosaceae. Revista Colombiana de Química, 48(2), 15-20.

Santos Júnior, H. M., Lopes, K. C., Alves, D. S., Carvalho, G. A., & Oliveira, D. F. (2018). Ursolic acid and cis-tiliroside produced by Merremia tomentosa affect oviposition of Leucoptera coffeella on coffee plants. Química Nova, 41, 302-309.

Hashmi, M. A., Khan, A., Hanif, M., Farooq, U., & Perveen, S. (2015). Traditional uses, phytochemistry, and pharmacology of Olea europaea (olive). Evidence-Based Complementary and Alternative Medicine, 2015.

Wang, C. M., Chen, H. T., Li, T. C., Weng, J. H., Jhan, Y. L., Lin, S. X., & Chou, C. H. (2014). The role of pentacyclic triterpenoids in the allelopathic effects of Alstonia scholaris. Journal of chemical ecology, 40, 90-98.

Jäger, S., Trojan, H., Kopp, T., Laszczyk, M. N., & Scheffler, A. (2009). Pentacyclic triterpene distribution in various plants–rich sources for a new group of multi-potent plant extracts. Molecules, 14(6), 2016-2031.

Zhou, C., Zhang, Y., Sheng, Y., Zhao, D., Lv, S., Hu, Y., & Tao, J. (2011). Herbaceous peony (Paeonia lactiflora Pall.) as an alternative source of oleanolic and ursolic acids. International Journal of Molecular Sciences, 12(1), 655-667.

Kowalski, R. (2007). Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types. Journal of Agricultural and Food chemistry, 55(3), 656-662.

Xia, E. Q., Wang, B. W., Xu, X. R., Zhu, L., Song, Y., & Li, H. B. (2011). Microwave-assisted extraction of oleanolic acid and ursolic acid from Ligustrum lucidum Ait. International journal of molecular sciences, 12(8), 5319-5329.

Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019). Ageing as a risk factor for neurodegenerative disease. Nature Reviews Neurology, 15(10), 565-581.

Wang, K., Sun, W., Zhang, L., Guo, W., Xu, J., Liu, S., ... & Zhang, Y. (2018). Oleanolic acid ameliorates Aβ25-35 injection-induced memory deficit in Alzheimer's Disease model rats by maintaining synaptic plasticity. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 17(5), 389-399.

Lin, K., Sze, S. C. W., Liu, B., Zhang, Z., Zhang, Z., Zhu, P., ... & Zhang, S. (2021). 20 (S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis. Journal of Ginseng Research, 45(2), 325-333.

Guo, Q., He, J., Zhang, H., Yao, L., & Li, H. (2020). Oleanolic acid alleviates oxidative stress in Alzheimer’s disease by regulating stanniocalcin‐1 and uncoupling protein‐2 signalling. Clinical and Experimental Pharmacology and Physiology, 47(7), 1263-1271.

Li, G., Hernandez-Ono, A., Crooke, R. M., Graham, M. J., & Ginsberg, H. N. (2011). Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism [S]. Journal of lipid research, 52(5), 971-981.

Castellano, J. M., Garcia-Rodriguez, S., Espinosa, J. M., Millan-Linares, M. C., Rada, M., & Perona, J. S. (2019). Oleanolic acid exerts a neuroprotective effect against microglial cell activation by modulating cytokine release and antioxidant defense systems. Biomolecules, 9(11), 683.

Ramírez-Espinosa, J. J., García-Jiménez, S., Rios, M. Y., Medina-Franco, J. L., López-Vallejo, F., Webster, S. P., ... & Estrada-Soto, S. (2013). Antihyperglycemic and sub-chronic antidiabetic actions of morolic and moronic acids, in vitro and in silico inhibition of 11β-HSD 1. Phytomedicine, 20(7), 571-576.

Mirza, F. J., Amber, S., Hassan, D., Ahmed, T., & Zahid, S. (2021). Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an Aβ1-42-induced mouse model of Alzheimer's disease. Phytomedicine, 83, 153490.

Yoon, J. H., Youn, K., Ho, C. T., Karwe, M. V., Jeong, W. S., & Jun, M. (2014). p-Coumaric acid and ursolic acid from corni fructus attenuated β-Amyloid25–35-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells. Journal of agricultural and food chemistry, 62(21), 4911-4916.

Hong, S. Y., Jeong, W. S., & Jun, M. (2012). Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules, 17(9), 10831-10845.

Chung, Y. K., Heo, H. J., Kim, E. K., Kim, H. K., Huh, T. L., Lim, Y., ... & Shin, D. H. (2001). Inhibitory effect of ursolic acid purified from Origanum majorana L. on the acetylcholinesterase. Molecules and cells, 11(2), 137-143.

Honarvar, F., Hojati, V., Bakhtiari, N., Vaezi, G., & Javan, M. (2019). Myelin protection by ursolic acid in cuprizone-induced demyelination in mice. Iranian Journal of Pharmaceutical Research: IJPR, 18(4), 1978.

Zhang, Y., Li, X., Ciric, B., Curtis, M. T., Chen, W. J., Rostami, A., & Zhang, G. X. (2020). A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proceedings of the National Academy of Sciences, 117(16), 9082-9093.

Xu, T., Wang, X., Zhong, B., Nurieva, R. I., Ding, S., & Dong, C. (2011). Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORγt protein. Journal of Biological Chemistry, 286(26), 22707-22710.

Ndlovu, B. C., Daniels, W. M., & Mabandla, M. V. (2014). Oleanolic Acid enhances the beneficial effects of preconditioning on PC12 cells. Parkinson’s Disease, 2014.

Mabandla, M. V., Nyoka, M., & Daniels, W. M. (2015). Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration. Brain research, 1622, 64-71.

Msibi, Z. N., & Mabandla, M. V. (2019). Oleanolic acid mitigates 6-hydroxydopamine neurotoxicity by attenuating intracellular ROS in PC12 cells and striatal microglial activation in rat brains. Frontiers in physiology, 10, 442062.

Rai, S. N., Yadav, S. K., Singh, D., & Singh, S. P. (2016). Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. Journal of Chemical Neuroanatomy, 71, 41-49.

Peshattiwar, V., Muke, S., Kaikini, A., Bagle, S., Dighe, V., & Sathaye, S. (2020). Mechanistic evaluation of ursolic acid against rotenone induced Parkinson’s disease–emphasizing the role of mitochondrial biogenesis. Brain Research Bulletin, 160, 150-161.

Zahra, W., Rai, S. N., Birla, H., Singh, S. S., Rathore, A. S., Dilnashin, H., ... & Singh, S. P. (2020). Neuroprotection of rotenone-induced parkinsonism by ursolic acid in PD mouse model. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 19(7), 527-540.

Shih, Y. H., Chein, Y. C., Wang, J. Y., & Fu, Y. S. (2004). Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats. Neuroscience letters, 362(2), 136-140.

Yi, L. T., Li, J., Liu, Q., Geng, D., Zhou, Y. F., Ke, X. Q., ... & Weng, L. J. (2013). Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. Journal of Psychopharmacology, 27(5), 459-468.

Yi, L. T., Li, J., Liu, B. B., Luo, L., Liu, Q., & Geng, D. (2014). BDNF–ERK–CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice. Journal of Psychiatry and Neuroscience, 39(5), 348-359.

Dong, S. Q., Wang, S. S., Zhu, J. X., Mu, R. H., Li, C. F., Geng, D., ... & Yi, L. T. (2019). Oleanolic acid decreases SGK1 in the hippocampus in corticosterone-induced mice. Steroids, 149, 108419.

Fajemiroye, J. O., Galdino, P. M., Florentino, I. F., Da Rocha, F. F., Ghedini, P. C., Polepally, P. R., ... & Costa, E. A. (2014). Plurality of anxiety and depression alteration mechanism by oleanolic acid. Journal of psychopharmacology, 28(10), 923-934.

Fajemiroye, J. O., Polepally, P. R., Chaurasiya, N. D., Tekwani, B. L., Zjawiony, J. K., & Costa, E. A. (2015). Oleanolic acid acrylate elicits antidepressant-like effect mediated by 5-HT1A receptor. Scientific reports, 5(1), 11582.

Chattopadhyay, D., Arunachalam, G., Mandal, S. C., Bhadra, R., & Mandal, A. B. (2003). CNS activity of the methanol extract of Mallotus peltatus (Geist) Muell Arg. leaf: an ethnomedicine of Onge. Journal of ethnopharmacology, 85(1), 99-105.

Colla, A. R., Oliveira, A., Pazini, F. L., Rosa, J. M., Manosso, L. M., Cunha, M. P., & Rodrigues, A. L. S. (2014). Serotonergic and noradrenergic systems are implicated in the antidepressant-like effect of ursolic acid in mice. Pharmacology Biochemistry and Behavior, 124, 108-116.

Colla, A. R., Pazini, F. L., Lieberknecht, V., Camargo, A., & Rodrigues, A. L. S. (2021). Ursolic acid abrogates depressive-like behavior and hippocampal pro-apoptotic imbalance induced by chronic unpredictable stress. Metabolic Brain Disease, 36, 437-446.

Ha, J. H., Lee, K. Y., Choi, H. C., Cho, J., Kang, B. S., Lim, J. C., & Lee, D. U. (2002). Modulation of radioligand binding to the GABAA-benzodiazepine receptor complex by a new component from Cyperus rotundus. Biological and Pharmaceutical Bulletin, 25(1), 128-130.

Awad, R., Muhammad, A., Durst, T., Trudeau, V. L., & Arnason, J. T. (2009). Bioassay‐guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 23(8), 1075-1081.

Colla, A. R., Rosa, J. M., Cunha, M. P., & Rodrigues, A. L. S. (2015). Anxiolytic-like effects of ursolic acid in mice. European journal of pharmacology, 758, 171-176.